Oral distribution of Candida species and presence of oral lesions in Brazilian leprosy patients under multidrug therapy

被引:12
作者
Ferraz de Araujo Navas, Edna Aparecida [1 ]
Inocencio, Aline Cassia [1 ]
Almeida, Janete Dias
Back-Brito, Graziella Nuernberg [1 ]
Mota, Adolfo Jose [2 ]
Cardoso Jorge, Antonio Olavo [1 ]
Rodrigues Querido, Silvia Maria [1 ]
Balducci, Ivan
Koga-Ito, Cristiane Yumi [1 ]
机构
[1] Univ Estadual Paulista, Sao Jose Campos Dent Sch, Sao Paulo State Univ, Microbiol Lab,Dept Biosci & Oral Diag, BR-12245000 Sao Paulo, Brazil
[2] Vale Paraiba Univ UNIVAP, Genet Lab, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Brazil; Candida; diagnosis; leprosy; oral; oral manifestations; DUBLINIENSIS; IDENTIFICATION; MANIFESTATIONS; PREVALENCE; VIRULENCE; CARRIAGE; CAVITY; YEAST; SPP;
D O I
10.1111/j.1600-0714.2009.00786.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: The aim of this study was to evaluate the prevalence of Candida spp. and presence of oral lesions in Brazilian leprosy patients under multidrug therapy (MDT). Methods: Thirty-eight individuals (18 males and 20 females, median age 53 years) clinically and microbiologically diagnosed as leprosy (lepromatous variant), and under MDT for at least 45 days were studied. The control group constituted by 38 healthy individuals (median age 53.5), matched to the test group in relation to age, gender and oral conditions. Oral rinses were collected and the Candida identification was performed by phenotypic tests. The existence of Candida dubliniensis among the isolates was analyzed using a validated multiplex PCR assay. Twenty-nine leprosy patients were examined intra-orally for the presence of lesions. Data were analyzed by z- and Mann-Whitney tests (alpha = 5%). Results: Yeast carriage rate between leprosy patients (65.8%) and controls (47.4%) was similar (P = 0.099), and no significant difference between yeast counts was observed (P = 0.1004). Candida albicans was the most frequently isolated species in both groups. In the leprosy group, Candida tropicalis and Candida parapsilosis were also identified. In the control group, we additionally identified Candida tropicalis, Candida glabrata and Candida kefyr. Candida dubliniensis was not detected. No leprosy-related oral lesion was registered. Conclusion: Within the limits of the study, we concluded that Brazilian leprosy patients under MDT showed similar levels of carriage and Candida species distribution in relation to the controls.
引用
收藏
页码:764 / 767
页数:4
相关论文
共 31 条
  • [1] Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait
    Ahmad, S
    Khan, Z
    Mokaddas, E
    Khan, ZU
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (07) : 633 - 637
  • [2] First isolation of Candida dubliniensis in Rio grande do sul, Brazil
    Alves, SH
    Milan, EP
    Moretti-Branchini, ML
    Nishimura, K
    Fukushima, K
    Oliveira, LO
    Costa, JM
    Colombo, AL
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 39 (03) : 165 - 168
  • [3] Frequency of Candida spp. in the Oral Cavity of Brazilian HIV-Positive Patients and Correlation with CD4 Cell Counts and Viral Load
    Back-Brito, G. N.
    Mota, A. J.
    Vasconcellos, T. C.
    Querido, S. M. R.
    Jorge, A. O. C.
    Reis, A. S. M.
    Balducci, I.
    Koga-Ito, Cristiane Yumi
    [J]. MYCOPATHOLOGIA, 2009, 167 (02) : 81 - 87
  • [4] Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects
    Campisi, G
    Pizzo, G
    Milici, ME
    Mancuso, S
    Margiotta, V
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2002, 93 (03): : 281 - 286
  • [5] CHAVASCO JK, 2006, REV INST MED TROP SP, V48, P1, DOI DOI 10.1590/S0036-46652006000100005
  • [6] Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences
    Donnelly, SM
    Sullivan, DJ
    Shanley, DB
    Coleman, DC
    [J]. MICROBIOLOGY-UK, 1999, 145 : 1871 - 1882
  • [7] Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
    Eggimann, P
    Garbino, J
    Pittet, D
    [J]. LANCET INFECTIOUS DISEASES, 2003, 3 (11) : 685 - 702
  • [8] GIRDHAR BK, 1979, LEPROSY REV, V50, P25
  • [9] GUTHRIE C, 1991, METHODS ENZIMOLOGY G
  • [10] Lenth R. V., JAVA APPLETS POWER S